Wednesday, September 16, 2026Latest filing Sep 14, 2026

DHR Congressional Stock Trades

DANAHER CORPORATION CMN

Last disclosed trade Jun 16

Every disclosed trade in DHR by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Pete Sessions · Sold $DHR · Jun 12 · $50K–$100K

0.66HIGH
Disclosure speedx 0.250.60
Trade sizex 0.250.75
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.350.80

Coldpine’s read

Sessions sits on Financial Services, though Danaher's life-sciences and diagnostics business falls outside his direct committee purview. The spouse-owned sale of $50K–$100K in DHR was held in a trust and disclosed within a relatively fast nine days. One other member made a same-direction trade in the name within 30 days, indicating some cluster activity.

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $DHR

Get notified when any member of Congress trades $DHR. Free, no card, no spam.

Follow free →
80
Disclosed trades
50
Buys
30
Sells
13
Members trading

The record on $DHR

Coldpine has parsed 80 disclosed trades in $DHR by 13 members of Congress, drawn from 47 periodic transaction reports dated Jan 9, 2023 through Jun 16, 2026. That is 79 trades from House members and 1 trade from senators, filed 54 by Democrats and 26 by Republicans.

Of the 80 trades with a known filing lag, 2 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 27 days. The longest was 116 days: a $DHR purchase by Alan Armstrong dated Mar 27, 2026, disclosed Jul 21, 2026. How late filing is measured across all of Congress is in the late-filers study.

71 of the 74 trades that list an account holder (96%) were reported under a spouse, dependent child, or joint account rather than the member directly.

Rohit Khanna filed the most $DHR purchases (31), and Rohit Khanna the most sales (19).

Activity peaked in 2025 with 28 trades. The busiest single month was September 2025, when 4 different members disclosed $DHR trades.

Across the 50 purchases Coldpine can price, $DHR moved +0.99% on average between the trade date and the disclosure date, against +2.00% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 54% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.

Members who trade DHR

Recent disclosed trades in DHR

DateMemberTypeAmount
Jun 16Rohit Khanna(CA)buy$1K–$15K
Jun 10Michael T. McCaul(TX)buy$1K–$15K
Jun 5Michael T. McCaul(TX)buy$1K–$15K
Jun 3Michael T. McCaul(TX)buy$1K–$15K
Jun 2Michael T. McCaul(TX)buy$1K–$15K
Jun 2Rohit Khanna(CA)buy$15K–$50K
May 22Michael T. McCaul(TX)buy$1K–$15K
May 14Michael T. McCaul(TX)buy$1K–$15K
May 4Michael T. McCaul(TX)buy$1K–$15K
Apr 28Michael T. McCaul(TX)buy$1K–$15K
Apr 24Rohit Khanna(CA)buy$1K–$15K
Apr 13Rohit Khanna(CA)buy$1K–$15K
Mar 27Alan Armstrong(OK)buy$1K–$15K
Mar 5Michael T. McCaul(TX)buy$1K–$15K
Nov 7Rohit Khanna(CA)sell$15K–$50K
Nov 3Rohit Khanna(CA)buy$1K–$15K
Oct 27Michael T. McCaul(TX)sell$15K–$50K
Oct 7Julie Johnson(TX)buy$1K–$15K
Oct 3Rohit Khanna(CA)buy$1K–$15K
Sep 25Michael T. McCaul(TX)buy$1K–$15K

Showing 20 of 80 disclosed trades.

Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).

Create a free account

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →